Nancy Olsen, MD
Disclosures: Consulting Fee-Consulting-Gilead|Contracted Research-Independent contractor (including contracted research)-Mallinckrodt, Inc.|Consulting Fee-Consulting-ChemoCentryx|Contracted Research-Independent contractor (including contracted research)-Resolve Therapeutics

Dr. Olsen is a native of Chicago and received her undergraduate degree in biology from Brown University.  She completed her MD at the University of Chicago and also received a MS in Immunology from that institution.  Her training in internal medicine was at the Medical College of Virginia, followed by a fellowship in rheumatology at the University of Texas Southwestern Medical Center.  She was a longtime member of the rheumatology division at Vanderbilt University where she worked with Tom Aune to develop gene expression as a way to identify patients at risk for autoimmune disease.  She then joined the UT Southwestern faculty.  While there, she worked with David Karp and Ward Wakeland on studies investigating patients who had features suggestive of a high risk for development of lupus.   She subsequently moved to Penn State MS Hershey Medical Center as director of the division of rheumatology.  Together with Dr. Karp, she led a U34 planning grant, with the objective of designing an interventional trial in patients with incomplete lupus features.  Subsequently this team, including Dr. Judith James and others, successfully competed for U01 funding from NIAMS for the SMILE trial, a placebo-controlled, multicenter intervention with hydroxychloroquine in patients with incomplete forms of lupus (ILE).  Her site is also a member of the Lupus Clinical Investigators Network and she is collaborating with Dr. Laura Carrel and Dajiang Liu on studies of incomplete X chromosome inactivation in patients with lupus.  Other research interests include interactions between the immune and endocrine systems with several recent publications on effects of pituitary hormones on B cell function.